Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionMHC class Ib protein binding

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.82e-1216526GO:0023029
GeneOntologyMolecularFunctionMHC class Ib receptor activity

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

6.12e-1219526GO:0032394
GeneOntologyMolecularFunctionMHC protein binding

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

8.45e-0958526GO:0042287
GeneOntologyMolecularFunctionimmune receptor activity

CSF3R KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.01e-08165528GO:0140375
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

EFNB3 CSF3R ROR2 PKD1 KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.15e-0513535213GO:0004888
GeneOntologyMolecularFunctionMHC class I receptor activity

KIR3DL1 KIR3DS1

9.91e-0418522GO:0032393
GeneOntologyMolecularFunctionextracellular matrix structural constituent

ZP1 FBN1 LAMA1 LAMB2

1.45e-03188524GO:0005201
GeneOntologyBiologicalProcessimmune response-regulating signaling pathway

MARK4 KIR3DL3 KIR2DS2 KIR2DL1 HCFC2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 EPG5

4.68e-096155413GO:0002764
GeneOntologyBiologicalProcessregulation of immune response

MARK4 KIR3DL3 KIR2DS2 KIR2DL1 HCFC2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 EPG5

3.24e-0610855413GO:0050776
GeneOntologyCellularComponentearly endosome membrane

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.56e-05212536GO:0031901
GeneOntologyCellularComponentlaminin-3 complex

LAMA1 LAMB2

1.89e-053532GO:0005608
GeneOntologyCellularComponentearly endosome

TBC1D2B KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

2.02e-04481537GO:0005769
GeneOntologyCellularComponentlaminin complex

LAMA1 LAMB2

2.80e-0410532GO:0043256
GeneOntologyCellularComponentprotein complex involved in cell-matrix adhesion

LAMA1 LAMB2

8.37e-0417532GO:0098637
GeneOntologyCellularComponentcytoplasmic vesicle membrane

CSF3R ROR2 PKD1 KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 ZDHHC13

1.46e-0313075310GO:0030659
GeneOntologyCellularComponentvesicle membrane

CSF3R ROR2 PKD1 KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 ZDHHC13

1.62e-0313255310GO:0012506
Domainig

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.52e-101905410PF00047
DomainImmunoglobulin

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.52e-101905410IPR013151
DomainIG

ROR2 KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.68e-084215411SM00409
DomainIg_sub

ROR2 KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.68e-084215411IPR003599
DomainIg-like_fold

CSF3R ROR2 KIR3DL3 KIR2DS2 KIR2DL1 HCFC2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

7.63e-087065413IPR013783
DomainIg-like_dom

CSF3R ROR2 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.63e-075035411IPR007110
Domain-

CSF3R ROR2 KIR2DS2 KIR2DL1 HCFC2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.17e-0766354122.60.40.10
DomainIG_LIKE

ROR2 KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

1.22e-064915410PS50835
DomainLaminin_N

LAMA1 LAMB2

9.59e-0416542IPR008211
DomainLAMININ_NTER

LAMA1 LAMB2

9.59e-0416542PS51117
DomainLaminin_N

LAMA1 LAMB2

9.59e-0416542PF00055
DomainLamNT

LAMA1 LAMB2

9.59e-0416542SM00136
DomainGrowth_fac_rcpt_

FBN1 IGFBP2 LAMA1 LAMB2

1.07e-03156544IPR009030
DomainEGF_LAM_2

LAMA1 LAMB2

3.39e-0330542PS50027
DomainEGF_LAM_1

LAMA1 LAMB2

3.39e-0330542PS01248
DomainLaminin_EGF

LAMA1 LAMB2

4.59e-0335542PF00053
DomainEGF_Lam

LAMA1 LAMB2

4.59e-0335542SM00180
DomainLaminin_EGF

LAMA1 LAMB2

5.40e-0338542IPR002049
PathwayKEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

7.00e-1188388M16004
PathwayREACTOME_DAP12_INTERACTIONS

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

5.96e-0954386MM14871
PathwayKEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

6.89e-08137387M5669
PathwayKEGG_GRAFT_VERSUS_HOST_DISEASE

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

7.56e-0841385M13519
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.48e-06135386MM14781
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DS1

6.75e-0646384M27151
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DL2

1.07e-05190386M8240
PathwayPID_INTEGRIN4_PATHWAY

LAMA1 LAMB2

3.83e-0411382M158
PathwayPID_INTEGRIN1_PATHWAY

FBN1 LAMA1 LAMB2

7.36e-0466383M18
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.98e-2614561019875891
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.98e-2614561015896204
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.98e-2614561019489269
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.49e-2515561020082646
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.49e-2515561020643584
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.49e-2515561019326408
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.49e-2515561019926642
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.49e-2515561020356536
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561019897003
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561019279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561017868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561018643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561019309280
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561019000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561020670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561019527230
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561020331834
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561020652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561018668235
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.97e-2516561020210919
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.64e-2517561020173792
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.64e-2517561019218127
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.64e-2517561020483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.64e-2517561019968064
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.64e-2517561020878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.64e-2517561020650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.64e-2517561019450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.64e-2517561019761533
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.17e-2418561019046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.17e-2418561019846535
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.17e-2418561019630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.17e-2418561020519398
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

2.17e-2418561020580654
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.57e-2419561018778326
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.57e-2419561018571006
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.57e-2419561020600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of ParanĂ¡.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

4.57e-2419561018848853
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.12e-2420561020193031
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.74e-2321561019861144
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

3.18e-2322561020492596
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

7.36e-231456918945962
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

1.84e-221556917498266
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

4.19e-221656916403292
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

8.90e-221756919032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL2 KIR3DS1

8.90e-221756920173784
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

8.90e-221756919169284
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

9.78e-2229561020082482
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

1.78e-211856920200544
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.78e-211856920210918
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

4.40e-211156819664392
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

6.13e-212056920426625
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

8.90e-2135561019683555
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

1.32e-201256820371502
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.32e-201256820137308
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

1.32e-201256819936734
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

1.32e-201256819181658
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.32e-201256817490516
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

3.43e-201356818687225
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

3.43e-201356819934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

3.43e-201356819120281
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

7.98e-201456819421224
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.52e-19856715730517
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

1.71e-191556819850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

1.71e-191556820207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

1.71e-191556819493232
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

6.82e-1995677749980
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

6.82e-1995678662091
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DL2

2.27e-181056712559621
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1

6.24e-181156718830515
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

9.24e-17756615748957
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4 KIR3DL1 KIR3DL2

9.24e-17756614607943
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

9.24e-17756611169255
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

9.24e-17756612618911
Pubmed

KIR haplotype content at the allele level in 77 Northern Irish families.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1

3.69e-16856617200871
Pubmed

Human diversity in killer cell inhibitory receptor genes.

KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DL2 KIR3DS1

3.69e-1685669430221
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

3.69e-16856618681957
Pubmed

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

1.11e-15956618340360
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR3DL3 KIR2DL2 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1

2.76e-151056621206914
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.01e-15556516112031
Pubmed

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

9.01e-1555657716543
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4

9.01e-15556510424431
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

9.01e-15556518755860
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DS1

5.40e-14656517882223
Pubmed

Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.89e-13756526928464
Pubmed

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1 KIR3DS1

1.89e-1375659430220
Pubmed

Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

KIR3DL3 KIR2DS2 KIR2DS1 KIR3DL2 KIR3DS1

1.13e-12956518074414
Pubmed

Distribution of KIR genes in the Czech population.

KIR3DL3 KIR2DL1 KIR2DS4 KIR3DL1 KIR3DL2

1.13e-12956518186800
Pubmed

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

KIR2DL2 KIR2DL3 KIR3DL1 KIR3DS1

6.03e-12456419522772
Pubmed

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

6.03e-12456418269867
Pubmed

Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

6.03e-12456426542066
Pubmed

Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

6.03e-12456418632158
Pubmed

Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

6.03e-12456423354323
Pubmed

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.01e-11556427893413
Pubmed

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL2

9.02e-11656419858347
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.

KIR2DS2 KIR2DS1 KIR3DL1 KIR3DS1

9.02e-11656420528243
Pubmed

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

4.20e-10856420935224
Pubmed

Distinctive KIR and HLA diversity in a panel of north Indian Hindus.

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

1.26e-091056411904677
Pubmed

Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.

KIR2DS2 KIR2DL1 KIR2DS1

3.95e-09356329549293
Pubmed

Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.

KIR2DL2 KIR2DL3 KIR2DS4

3.95e-09356326031759
Pubmed

KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.

KIR2DS4 KIR3DL1 KIR3DS1

3.95e-09356319859704
InteractionKIR2DL2 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1 KIR3DS1

1.45e-1013545int:KIR2DL2
InteractionKIR3DL1 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1

3.23e-0813544int:KIR3DL1
InteractionKIR2DS2 interactions

KIR2DS2 KIR2DL2 KIR2DS1 KIR3DL1

2.85e-0637544int:KIR2DS2
InteractionHLA-C interactions

ROR2 KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

4.22e-06353548int:HLA-C
InteractionKIR2DS3 interactions

KIR2DS2 KIR2DL1 KIR2DL2

2.01e-0520543int:KIR2DS3
InteractionKIR2DS1 interactions

KIR2DS2 KIR2DS1

4.21e-054542int:KIR2DS1
InteractionKIR3DP1 interactions

KIR2DS2 KIR2DL1

4.21e-054542int:KIR3DP1
InteractionKIR2DL1 interactions

KIR2DL1 KIR2DL2 KIR3DL1

5.68e-0528543int:KIR2DL1
InteractionFAM114A2 interactions

KIR2DL1 KIR2DL2 KIR3DL1 KIR3DL2

7.58e-0584544int:FAM114A2
Cytoband19q13.4

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

5.86e-167956919q13.4
CytobandEnsembl 112 genes in cytogenetic band chr19q13

MARK4 KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2 ZNF865 AKT1S1

1.32e-051192569chr19q13
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1

1.07e-23183610620
GeneFamilyADAM metallopeptidase domain containing|CD molecules

CSF3R KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

3.31e-093943610471
GeneFamilyLaminin subunits

LAMA1 LAMB2

2.51e-0412362626
GeneFamilyForkhead boxes

FOXQ1 FOXD1

3.31e-0343362508
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR3DL1

8.45e-1249547M40909
CoexpressionGSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN

KIR3DL3 KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 AKT1S1 FOXD1

1.83e-10190549M4662
CoexpressionHAHTOLA_SEZARY_SYNDROM_DN

KIR3DL3 KIR2DS4 KIR3DL1 KIR3DL2

1.87e-0643544M18968
CoexpressionGSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN

KIR2DS2 ZFTA KIR2DL1 KIR2DL2 KIR2DL3 KIR3DS1

3.39e-06199546M9885
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL

KIR2DL1 KIR2DL3 KIR3DL1

6.60e-0618543M45763
CoexpressionNABA_ECM_GLYCOPROTEINS

ZP1 FBN1 IGFBP2 LAMA1 LAMB2

4.62e-05191545MM17059
CoexpressionNABA_ECM_GLYCOPROTEINS

ZP1 FBN1 IGFBP2 LAMA1 LAMB2

5.22e-05196545M3008
CoexpressionHEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED

LAMA1 LAMB2

6.22e-056542M48000
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGFBP2 MYO7A KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

4.38e-08168526b4bb03efb601a61465260f93896c56861c588bef
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGFBP2 MYO7A KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

4.38e-08168526240ea32b64d86f9216785010d6b237d9adf052c9
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGFBP2 MYO7A KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

4.53e-08169526e7470a5b060881b2a8ce2ab04b0788396aa13889
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGFBP2 MYO7A KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

5.03e-08172526e3a8891694343b6b01e80a200ae338d24797e417
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NAALADL1 IGFBP2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

8.53e-081885269abd78970bbe4ed03b59a83da63bbd334712f605
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NAALADL1 IGFBP2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

8.53e-08188526f7dc29dfec68236883469e848be5db34f5526d6b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NAALADL1 IGFBP2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

8.53e-081885265ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1
ToppCellBL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2 TAMALIN

1.09e-07196526cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|GI_small-bowel / Manually curated celltypes from each tissue

SP6 KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

1.04e-061555251c67f58ed79331addbc012dab0cb09a7f350aedb
ToppCell367C-Lymphocytic-NK_cells-NK_cell_C|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

1.07e-06156525a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

1.68e-06171525adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 TAMALIN

1.73e-06172525701de463f85aaad3a4b36a0d5fbc416406620089
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

1.78e-0617352579d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.16e-061805250a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.16e-061805251c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.16e-06180525ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

2.54e-061865251590fe72badffc79f1d390deb3207116ac2281bb
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

2.54e-06186525e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SARAF KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.61e-06187525931f9d16ce541bb6979f7f179bcae21816721294
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.68e-061885250a2be6eac6fde669fbc58fd1b2e93e4acf17ddde
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.89e-06191525f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.97e-06192525e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.97e-061925254d72b9264ed62e0c08cde4078061b348253f6989
ToppCellnormal_Pleural_Fluid-T/NK_cells-NK|normal_Pleural_Fluid / Location, Cell class and cell subclass

NAALADL1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.97e-0619252559dd4f5ae9f1cca78adf60b71661092ef09e6641
ToppCellTracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.04e-0619352591a1c9b8390cbd881db8c49d8f34feca0d1067d6
ToppCellICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.04e-06193525f110f86db305e41639087f5b1a2dff103c07adf0
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|bone_marrow / Manually curated celltypes from each tissue

PNRC1 SARAF KIR2DL3 KIR3DL1 KIR3DL2

3.04e-061935251788f865fc9f9a235dbfaf363ed1985fdc715394
ToppCell10x5'v1-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SARAF KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.12e-061945255a859885c0f9b8554b0d203e371c70928ad4418f
ToppCell367C-Lymphocytic-NK_cells|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.12e-061945252e447de50b3f4b59e3b9928df83879955fed93cc
ToppCell10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 TAMALIN

3.12e-06194525c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SARAF KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.12e-061945257d35ac70ba966eb1fee4197f7de6d6116326a442
ToppCellLeuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.12e-0619452536afc4e48d267be3b8aa1e33fad043bcd54c6bc5
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.12e-06194525ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.12e-061945253a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCellIIF-Lymphocyte-T_NK-NK|IIF / Disease, Lineage and Cell Type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.20e-06195525464ce05cb52f78aee22d3baa6641b37bd53aae16
ToppCell10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue

PNRC1 SARAF KIR2DL3 KIR3DL1 KIR3DL2

3.20e-06195525972b09697b7b66fb8a27dfc0c0b05a844121f055
ToppCell10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 TAMALIN

3.20e-06195525c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb
ToppCellmetastatic_Brain-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass

PNRC1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.20e-06195525184471f71b8bbffec12ebb8dd6a0af589e021c02
ToppCellCOVID-19_Severe-Lymphoid_T/NK-NK|COVID-19_Severe / Disease group, lineage and cell class

NAALADL1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.28e-06196525cc1daf12de5765ba4f7002396352404b41df2012
ToppCell367C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

IGFBP2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.28e-06196525c6fac4ead13834483e780188de7d417e5cf37611
ToppCellSevere-NK|Severe / Disease group and Cell class

IGFBP2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.28e-0619652566130d38b67e51e2385de8a89227759fd137999c
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

NAALADL1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.28e-06196525d3bd8fab010e76024d7e06aba0ea5df3394f411f
ToppCell10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 TAMALIN

3.28e-06196525e6d4853ccefbcd45a019cee595811f0474dcc036
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NAALADL1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.28e-0619652577da6b1bcab45d376eb0368f540e0ed24ce98b42
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAALADL1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.36e-061975259993fdea353abeafc009ac87439ad25cedf8f1f6
ToppCellPBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAALADL1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.36e-06197525a8b41fffa4e86f2766423392951ff320e821a19a
ToppCellSevere-NK|World / Disease group and Cell class

IGFBP2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.36e-061975251e5fb79385657a467c2d9f942d8cafb8ef7826c9
ToppCellsevere-Lymphocytic-NK_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.36e-061975258bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCelltumor_Lung-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass

IGFBP2 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.36e-06197525e9fac2c923179b2b8b0500076421c6fb09960b56
ToppCellsevere-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.45e-061985256ef22f33b43e9adceea11738e3cba0e8b59b4ec6
ToppCellSevere-Lymphoid-NK|Severe / Condition, Lineage, Cell class and cell subclass

NAALADL1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.45e-0619852526b6d20527d22ce68067cdaea6b4330cb779f91b
ToppCellmild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.45e-06198525dce3c008757786aa6bd4a869456b76b4cbbb1d5b
ToppCellmild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.45e-061985251d20fc9948965de52a98f758035edfdd12cafc5f
ToppCellURO-Lymphocyte-T_NK-NK|URO / Disease, Lineage and Cell Type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.45e-061985252ccff882aafabf041df15b31d9abc50dcbc2696e
ToppCellcontrol-Lymphocytic-NK_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.45e-061985251c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCellsevere_COVID-19-NK|World / disease group, cell group and cell class (v2)

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2 TAMALIN

3.45e-0619852536b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A|390C / Donor, Lineage, Cell class and subclass (all cells)

PNRC1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.53e-06199525f72db89fe7e511473fc849f8fadb8b6453ac8ae5
ToppCellcontrol-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DL2

3.53e-061995258aca7775b3d34fd26c7b23ddb23f5f2df72684b0
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PNRC1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.53e-061995250902b08e3386e64d7347c186d9ce5b67f2deaabb
ToppCellBiopsy_Control_(H.)-Immune-NK_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.62e-06200525c93393d52ed1c238d539f254fd2a95eb101a6f65
ToppCellCaecum-(1)_T_cell-(17)_gd_T|Caecum / shred on region, Cell_type, and subtype

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.62e-062005252aaa6b37e9f8d95de53f284a42a3ac14e6351b40
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK|COVID-19_Severe / Disease, condition lineage and cell class

NAALADL1 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.62e-062005252580b7b83ba707718fe23ffca986e7a55ea85bce
ToppCellsevere-NK|World / disease stage, cell group and cell class

NAALADL1 IGFBP2 KIR2DL1 KIR2DL3 KIR3DL2

3.62e-06200525320cb0d79adaa1b43d90d027a876cd74f8b55ec3
ToppCellCaecum-T_cell-gd_T|Caecum / Region, Cell class and subclass

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.62e-06200525eaacd14b6d4a1c7d52deab110ed3a6c7d3dc1f8e
ToppCell(17)_gd_T|World / shred on Cell_type and subtype

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.71e-062015257fcfe48758acf07cb3dda939ce589ae1518e41c9
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-8|TCGA-Lung / Sample_Type by Project: Shred V9

KIR3DL3 KIR2DL3 KIR2DS4 KIR3DL1

9.97e-0611552455a56828f86c004cd11d1a426a03e86246e949a3
ToppCell368C-Lymphocytic-NK_cells-NK_cell_A|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

2.55e-051465240e38e1fa40b1fcd1bb61f7af7cc2206846c192ae
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 ZDHHC13

2.62e-051475243ed5b020ce1f1277917d79ef1f7da53fa474e8db
ToppCellCerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32

C1QL1 ROR2 LAMA1 FOXD1

2.76e-051495243980fa4f1986a2f164a1826ea043fb71f1d756cd
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 ZDHHC13

3.14e-05154524ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad
ToppCell367C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL2

3.31e-05156524e6798d2b9c2c1fc6525c24f596f25aa85a375651
ToppCell368C-Lymphocytic-NK_cells|368C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.39e-05157524ef5c0ace4cd500b6cc50fb7076298f3d3543b40c
ToppCellfrontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

IGFBP2 LAMA1 LAMB2 FOXD1

3.56e-0515952434c90711c5857cf6ada7b3acff99f1d48c7caf29
ToppCellHippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32

IGFBP2 ROR2 LAMA1 FOXD1

3.56e-0515952492049a8d8fc9997d8d0d76500c72596a9b2394e0
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.74e-05161524f7dc1e3326ab22f2eb1e94b632469a0682a3289c
ToppCell367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells)

MYO7A KIR2DL1 KIR2DL3 KIR3DL2

3.83e-0516252474cd0de957fdbe527656befd61f67d6814ce9e98
ToppCell390C-Lymphocytic-NK_cells-NK_cell_B2|390C / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL3 KIR3DL1 KIR3DL2

3.93e-05163524036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

3.93e-05163524466c8129852a5b16cd9fcc6b79e799abc21bb21a
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

IGFBP2 ROR2 LAMA1 FOXD1

4.12e-05165524570483b43ccb5831feec9337b4664814431d40b1
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

IGFBP2 ROR2 LAMA1 FOXD1

4.12e-051655242026a9a07f4d314cc05c167e491312b373468e46
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BLOC1S4 SP6 PNRC1 FOXD1

4.31e-051675244ae9f2c5df13463709ea880ab035965fd99e7626
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BLOC1S4 SP6 PNRC1 FOXD1

4.31e-051675244e58f9bf1e9d47720c871776ec34513ded4de9b7
ToppCellfrontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

IGFBP2 LAMA1 LAMB2 FOXD1

4.73e-051715242e43fb129ee9bdc3b31febc43c10f959bf0f4a7d
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR3DL3 KIR2DL3 KIR3DL1 KIR3DL2

4.73e-051715244ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCellfrontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

IGFBP2 LAMA1 LAMB2 FOXD1

4.73e-05171524e219a1aa59a96e4bc3e2eacf985679174a51de41
ToppCelldroplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX7 MYO7A MARK4 HCFC2

4.95e-05173524fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f
ToppCelldroplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXQ1 IGFBP2 LAMA1 SYDE1

5.06e-05174524a0ccda8fd6f55251cdeff24cf66e72e4a31d2104
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PNRC1 ZFTA CHPF TAMALIN

5.06e-0517452466a3b20ff1ab9f36fb391986444d7dc99d0c03d1
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

5.18e-051755248fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4
ToppCellfacs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBN1 MYO7A ACR SYDE1

5.29e-051765243766e0533b103ec92ac75eba3df02e287efc53fa
ToppCellfacs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBN1 MYO7A ACR SYDE1

5.29e-05176524aa1bada2175d8370fc71939a607407155259d195
ToppCellwk_15-18-Hematologic_Lymphocytic-NK-Activated_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1

5.29e-051765246802ed40eb0f91674d4f0120a3d4888c8a2e9612
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9

KIR2DL1 KIR2DS4 KIR3DL2 FOXD1

5.29e-051765241870860a9ebe7a655c4ea8898427e1097ee23113
ToppCell10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

5.41e-051775240f2616a81f8fbede77c860b2126e3fa826672da3
ToppCellfacs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBN1 IGFBP2 ROR2 OPLAH

5.53e-051785246d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCellfacs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBN1 IGFBP2 ROR2 OPLAH

5.53e-05178524d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK|GI_small-bowel / Manually curated celltypes from each tissue

IGFBP2 KIR2DL1 KIR2DL3 KIR3DL1

5.65e-05179524535bdfdd990ba9ee3edc8f3ad15297f8fb5a266e
ToppCell367C-Lymphocytic-NK_cells-NK_cell_A|367C / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

5.77e-05180524023c83f0c9d0280983c6fd28ecf04bfa6b1b89e2
ToppCell5'-Adult-LargeIntestine-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PNRC1 KIR2DL1 KIR2DL3 KIR3DL1

6.16e-05183524b902390614fe924d48511e4187b36a0b49b08f23
ToppCell367C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

KIR2DL1 KIR2DL3 KIR3DL1 KIR3DL2

6.42e-0518552425781cf68e693e97dc1885e2879ab24fa946b51e
ComputationalNeighborhood of IL2RB

KIR3DL3 KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1 KIR3DL2

1.21e-0946276GNF2_IL2RB
ComputationalOvary genes.

FBN1 IGFBP2 ROR2 PKD1 TBC1D2B LAMB2 PNRC1 CHPF

2.19e-06368278MODULE_1
ComputationalHeart genes.

IGFBP2 ACR ROR2 PKD1 LAMB2 PNRC1 CHPF

6.23e-05423277MODULE_60
ComputationalPlacenta genes.

IGFBP2 CSF3R ROR2 TBC1D2B LAMB2 CHPF FOXD1

1.10e-04463277MODULE_38
ComputationalGenes in the cancer module 85.

EFNB3 CSF3R ROR2

2.72e-0451273MODULE_85
ComputationalGenes in the cancer module 199.

EFNB3 CSF3R ROR2

3.78e-0457273MODULE_199
ComputationalGenes in the cancer module 138.

CSF3R ACR ROR2

1.30e-0387273MODULE_138
ComputationalGenes in the cancer module 27.

EFNB3 CSF3R ROR2 KIR2DL3 KIR3DL1

1.69e-03355275MODULE_27
DrugAa1

ACR KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

4.80e-1383569CID009549188
DrugD-Au

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2

1.47e-1177568CID000277822
Drug1xa5

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

1.09e-0793566CID000157684
DrugAb-9

KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

1.90e-0721564CID006540280
Drugglycoluril

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

1.97e-0753565CID000062347
DrugAC1L1AQK

KIR3DL3 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL2

4.71e-07119566CID000001105
Drug6-carboxyfluorescein diacetate

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL2

8.57e-0730564CID000151095
Drugpristane

KIR3DL3 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR3DL2

1.98e-06152566CID000015979
DrugMarathon

KIR3DL3 KIR2DS1 KIR2DS4 OPLAH

8.79e-0653564CID000034469
DrugNSC237521

KIR3DL3 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

1.27e-05210566CID000428410
Drug1c88

KIR3DL3 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

1.46e-05126565CID000444766
DrugC2(+)

KIR3DL1 KIR3DL2

1.78e-053562CID006857645
DrugAGN 1135

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 KIR3DL2

2.51e-05141565CID000122316
Drug2-nitro-p-cresol

KIR3DL3 KIR2DS1 KIR2DS4 KIR3DL2

3.69e-0576564CID000008391
Drug2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine

FBN1 CSF3R LAMA1 LAMB2

5.22e-0583564CID011968896
DrugAC1ODVCS

KIR2DL2 KIR2DL3 KIR3DL2

5.46e-0530563CID000111104
Drugbunazosin

KIR3DL3 KIR2DS1 KIR2DS4

6.65e-0532563CID000002472
DrugAzacitidine

LAMA1 LAMB2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1

6.83e-05415567ctd:D001374
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR3DL3 KIR2DL1 KIR2DL3

5.16e-093523OBA_2042107
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR3DL3 KIR2DL1 KIR2DL3

2.31e-0615523EFO_0801746
Diseaseacquired immunodeficiency syndrome (is_implicated_in)

KIR2DL1 KIR3DS1

1.09e-049522DOID:635 (is_implicated_in)
Diseasekiller cell immunoglobulin-like receptor 2DL4 measurement

KIR2DS4 KIR3DL2

1.99e-0412522EFO_0008197
Diseasemalaria (is_implicated_in)

KIR3DL1 KIR3DS1

8.20e-0424522DOID:12365 (is_implicated_in)
Diseasetuberculosis (is_implicated_in)

KIR3DL1 KIR3DS1

1.12e-0328522DOID:399 (is_implicated_in)
Diseasehepatitis C (is_implicated_in)

KIR3DL1 KIR3DS1

1.12e-0328522DOID:1883 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
HRPGPQYGLPIDGCI

EPG5

1321

Q9HCE0
PGPCAYAAHGRGALA

AKT1S1

41

Q96B36
DHGPPRLSYCGGGEA

C8orf82

121

Q6P1X6
AGYAACLLPGAGARP

BLOC1S4

66

Q9NUP1
RFIGPGCLPHFKAGL

ACR

156

P10323
VCDPYPARGPGAGAR

C1QL1

31

O75973
AVGGHPRGPGEYCHL

CCDC144NL

181

Q6NUI1
GAFHPAPLPLGACGA

CELF6

231

Q96J87
AFGYRPHPLGAALPG

FOXD1

326

Q16676
PLGPATHGGTYRCFG

KIR2DS2

186

P43631
PLGPATHGGTYRCFG

KIR3DL2

281

P43630
CPQALGHPPGGDGYF

NOBOX

611

O60393
RAGPFGYPRDGHPLS

PARD3B

976

Q8TEW8
PLGPATHGGTYRCFG

KIR2DL2

186

P43627
PLGPATHGGTYRCFG

KIR2DS4

186

P43632
GLPPCPRLGHSFSLY

HCFC2

121

Q9Y5Z7
PLGPATHGGTYRCFG

KIR2DL3

186

P43628
AHCILGLPGGSSYPP

LMO7DN

81

F2Z398
PLGPATHGGTYRCFG

KIR3DL1

281

P43629
FLPHFLGGDGPCLTP

PNRC1

56

Q12796
GQGLRCYPHPGSELP

IGFBP2

106

P18065
PLGPVTHGGNYRCFG

KIR3DL3

281

Q8N743
GFHGDPRLPYGGQCR

LAMB2

911

P55268
CLYGAGLLPGSLPFG

TAMALIN

246

Q7Z6J2
LAGGLADGLGPHPCF

MFSD3

376

Q96ES6
IGYHYPPICLGRAPG

ERVK-6

156

Q69384
LCGCPPGYFRIGQGH

FBN1

2671

P35555
LGSPTSPGPGHYLRC

CSF3R

756

Q99062
DFCLPGGRYLPHGLG

MBLAC1

136

A4D2B0
PQPFLLACLHGGAGG

MARK4

691

Q96L34
GPPCLRPLFGGLGGY

FLAD1

71

Q8NFF5
ALRGGGAADPPFCPH

EFNB3

296

Q15768
PLGPATHGGTYRCFG

KIR2DL1

186

P43626
LPLCAYGAGEPARLG

FOXQ1

321

Q9C009
PLRGPAAGGAHLYCP

FOXQ1

361

Q9C009
RSLLCYGGAPGPGCH

PKD1

2791

P98161
PLGPATHGGTYRCFG

KIR2DS1

186

Q14954
FRGCPHVLGYEGPGD

RUNDC1

131

Q96C34
HLYGLGGLRPAPGAT

SYDE1

271

Q6ZW31
LPSLRGCYHEGPAGG

SOX7

171

Q9BT81
GPGAAGYCLLLGLHL

SARAF

6

Q96BY9
AHPGPACYRKGGPVT

OPLAH

376

O14841
CAPGYHRGKLPAGSD

LAMA1

1376

P25391
PLGPATHGGTYRCFG

KIR3DS1

281

Q14943
PELGGGHAYCRNPGG

ROR2

356

Q01974
YLLSCGFPPRPAHGD

SEZ6L2

286

Q6UXD5
GLGGYVGDHQLCAPP

SP6

151

Q3SY56
DFIGGEPTPGRYCHG

CHPF

231

Q8IZ52
EPTPGRYCHGGFGVL

CHPF

236

Q8IZ52
GAGAGGPRPVYPCDL

ZNF865

431

P0CJ78
GPHPPGFGRYGICAH

ZDHHC13

16

Q8IUH4
DPGLPGLRHSYDCGI

ZP1

31

P60852
KHGSCEDPGGYRLPL

WDR25

66

Q64LD2
GHPTRGYPCGIAFSP

WDR27

751

A2RRH5
PGAGPAREPARLCGY

TBC1D2B

26

Q9UPU7
AALRCYGHEGFGPPA

ZFTA

646

C9JLR9
FVPLRGSPHRGPGCY

PIFO

36

Q8TCI5
LGCHYRLGPGFRPDG

NAALADL1

311

Q9UQQ1
IHGGPPGYAPYCEER

MYO7A

1216

Q13402